ArticleTransplantation and cellular therapy2021

Letermovir for Prevention of Cytomegalovirus Reactivation in Haploidentical and Mismatched Adult Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.

Andrew Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.